nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—Breast mass—Octreotide—thymus cancer	0.174	0.358	CcSEcCtD
Diazoxide—KCNMA1—pulmonary artery—thymus cancer	0.0992	0.193	CbGeAlD
Diazoxide—Galactorrhoea—Octreotide—thymus cancer	0.0309	0.0636	CcSEcCtD
Diazoxide—GLUL—neck—thymus cancer	0.0221	0.0429	CbGeAlD
Diazoxide—Drug interaction—Octreotide—thymus cancer	0.0216	0.0445	CcSEcCtD
Diazoxide—GLUL—hematopoietic system—thymus cancer	0.0164	0.032	CbGeAlD
Diazoxide—KCNJ11—hematopoietic system—thymus cancer	0.0154	0.03	CbGeAlD
Diazoxide—KCNMA1—hematopoietic system—thymus cancer	0.0153	0.0297	CbGeAlD
Diazoxide—GLUL—epithelium—thymus cancer	0.015	0.0292	CbGeAlD
Diazoxide—KCNMA1—epithelium—thymus cancer	0.0139	0.0271	CbGeAlD
Diazoxide—ATP1A1—neck—thymus cancer	0.0132	0.0256	CbGeAlD
Diazoxide—SLC12A3—lung—thymus cancer	0.0128	0.0249	CbGeAlD
Diazoxide—Pancreatitis—Octreotide—thymus cancer	0.0123	0.0254	CcSEcCtD
Diazoxide—GLUL—pituitary gland—thymus cancer	0.0122	0.0237	CbGeAlD
Diazoxide—Abdominal discomfort—Octreotide—thymus cancer	0.012	0.0248	CcSEcCtD
Diazoxide—CA1—hematopoietic system—thymus cancer	0.0116	0.0225	CbGeAlD
Diazoxide—GLUL—lymphoid tissue—thymus cancer	0.0116	0.0225	CbGeAlD
Diazoxide—Weight increased—Octreotide—thymus cancer	0.0114	0.0236	CcSEcCtD
Diazoxide—Hyperglycaemia—Octreotide—thymus cancer	0.0113	0.0233	CcSEcCtD
Diazoxide—KCNJ11—lymphoid tissue—thymus cancer	0.0109	0.0211	CbGeAlD
Diazoxide—Haematuria—Octreotide—thymus cancer	0.0107	0.022	CcSEcCtD
Diazoxide—ABCC8—pituitary gland—thymus cancer	0.0105	0.0205	CbGeAlD
Diazoxide—GLUL—bone marrow—thymus cancer	0.0105	0.0205	CbGeAlD
Diazoxide—GLUL—thyroid gland—thymus cancer	0.0105	0.0204	CbGeAlD
Diazoxide—CA2—neck—thymus cancer	0.0101	0.0196	CbGeAlD
Diazoxide—KCNJ11—thyroid gland—thymus cancer	0.00987	0.0192	CbGeAlD
Diazoxide—ATP1A1—hematopoietic system—thymus cancer	0.0098	0.0191	CbGeAlD
Diazoxide—KCNMA1—thyroid gland—thymus cancer	0.00976	0.019	CbGeAlD
Diazoxide—GLUL—lung—thymus cancer	0.00955	0.0186	CbGeAlD
Diazoxide—Flushing—Octreotide—thymus cancer	0.00933	0.0192	CcSEcCtD
Diazoxide—ABCC8—thyroid gland—thymus cancer	0.00909	0.0177	CbGeAlD
Diazoxide—ATP1A1—epithelium—thymus cancer	0.00896	0.0174	CbGeAlD
Diazoxide—KCNMA1—lung—thymus cancer	0.00886	0.0172	CbGeAlD
Diazoxide—Vision blurred—Octreotide—thymus cancer	0.00825	0.017	CcSEcCtD
Diazoxide—CA1—lymphoid tissue—thymus cancer	0.00816	0.0159	CbGeAlD
Diazoxide—Ill-defined disorder—Octreotide—thymus cancer	0.00812	0.0167	CcSEcCtD
Diazoxide—Malaise—Octreotide—thymus cancer	0.00789	0.0163	CcSEcCtD
Diazoxide—Palpitations—Octreotide—thymus cancer	0.00774	0.0159	CcSEcCtD
Diazoxide—Hypertension—Octreotide—thymus cancer	0.00756	0.0156	CcSEcCtD
Diazoxide—CA2—hematopoietic system—thymus cancer	0.00751	0.0146	CbGeAlD
Diazoxide—Chest pain—Octreotide—thymus cancer	0.00745	0.0154	CcSEcCtD
Diazoxide—ATP1A1—cardiac atrium—thymus cancer	0.00744	0.0145	CbGeAlD
Diazoxide—CA1—bone marrow—thymus cancer	0.00743	0.0144	CbGeAlD
Diazoxide—Anxiety—Octreotide—thymus cancer	0.00743	0.0153	CcSEcCtD
Diazoxide—Discomfort—Octreotide—thymus cancer	0.00736	0.0152	CcSEcCtD
Diazoxide—ATP1A1—pituitary gland—thymus cancer	0.00727	0.0141	CbGeAlD
Diazoxide—Oedema—Octreotide—thymus cancer	0.00714	0.0147	CcSEcCtD
Diazoxide—Thrombocytopenia—Octreotide—thymus cancer	0.007	0.0144	CcSEcCtD
Diazoxide—Tachycardia—Octreotide—thymus cancer	0.00697	0.0144	CcSEcCtD
Diazoxide—Hyperhidrosis—Octreotide—thymus cancer	0.00691	0.0142	CcSEcCtD
Diazoxide—ATP1A1—lymphoid tissue—thymus cancer	0.0069	0.0134	CbGeAlD
Diazoxide—CA2—epithelium—thymus cancer	0.00687	0.0133	CbGeAlD
Diazoxide—Anorexia—Octreotide—thymus cancer	0.00681	0.014	CcSEcCtD
Diazoxide—CA1—lung—thymus cancer	0.00673	0.0131	CbGeAlD
Diazoxide—GLUL—lymph node—thymus cancer	0.00653	0.0127	CbGeAlD
Diazoxide—Insomnia—Octreotide—thymus cancer	0.00646	0.0133	CcSEcCtD
Diazoxide—Paraesthesia—Octreotide—thymus cancer	0.00642	0.0132	CcSEcCtD
Diazoxide—ATP1A1—bone marrow—thymus cancer	0.00628	0.0122	CbGeAlD
Diazoxide—ATP1A1—thyroid gland—thymus cancer	0.00627	0.0122	CbGeAlD
Diazoxide—Decreased appetite—Octreotide—thymus cancer	0.00621	0.0128	CcSEcCtD
Diazoxide—KCNJ11—lymph node—thymus cancer	0.00613	0.0119	CbGeAlD
Diazoxide—Pain—Octreotide—thymus cancer	0.00611	0.0126	CcSEcCtD
Diazoxide—KCNMA1—lymph node—thymus cancer	0.00606	0.0118	CbGeAlD
Diazoxide—Feeling abnormal—Octreotide—thymus cancer	0.00589	0.0121	CcSEcCtD
Diazoxide—Gastrointestinal pain—Octreotide—thymus cancer	0.00584	0.012	CcSEcCtD
Diazoxide—CA2—cardiac atrium—thymus cancer	0.0057	0.0111	CbGeAlD
Diazoxide—ATP1A1—lung—thymus cancer	0.00569	0.0111	CbGeAlD
Diazoxide—Abdominal pain—Octreotide—thymus cancer	0.00565	0.0116	CcSEcCtD
Diazoxide—Body temperature increased—Octreotide—thymus cancer	0.00565	0.0116	CcSEcCtD
Diazoxide—CA2—pituitary gland—thymus cancer	0.00557	0.0108	CbGeAlD
Diazoxide—CA2—lymphoid tissue—thymus cancer	0.00529	0.0103	CbGeAlD
Diazoxide—Hypersensitivity—Octreotide—thymus cancer	0.00526	0.0108	CcSEcCtD
Diazoxide—Asthenia—Octreotide—thymus cancer	0.00513	0.0106	CcSEcCtD
Diazoxide—Pruritus—Octreotide—thymus cancer	0.00505	0.0104	CcSEcCtD
Diazoxide—Diarrhoea—Octreotide—thymus cancer	0.00489	0.0101	CcSEcCtD
Diazoxide—CA2—bone marrow—thymus cancer	0.00482	0.00936	CbGeAlD
Diazoxide—CA2—thyroid gland—thymus cancer	0.0048	0.00934	CbGeAlD
Diazoxide—Dizziness—Octreotide—thymus cancer	0.00472	0.00973	CcSEcCtD
Diazoxide—CA1—lymph node—thymus cancer	0.0046	0.00895	CbGeAlD
Diazoxide—Vomiting—Octreotide—thymus cancer	0.00454	0.00936	CcSEcCtD
Diazoxide—Rash—Octreotide—thymus cancer	0.0045	0.00928	CcSEcCtD
Diazoxide—Dermatitis—Octreotide—thymus cancer	0.0045	0.00927	CcSEcCtD
Diazoxide—Headache—Octreotide—thymus cancer	0.00448	0.00922	CcSEcCtD
Diazoxide—CA2—lung—thymus cancer	0.00436	0.00848	CbGeAlD
Diazoxide—Nausea—Octreotide—thymus cancer	0.00424	0.00874	CcSEcCtD
Diazoxide—ATP1A1—lymph node—thymus cancer	0.00389	0.00757	CbGeAlD
Diazoxide—CA2—lymph node—thymus cancer	0.00298	0.0058	CbGeAlD
